Tag: VEITH 2023
FORS-powered LumiGuide 3D imaging technology is rolled out at specialized centers...
Andres Schanzer, MD, has hailed it "one of the most exciting changes" seen in imaging during the course of his career. Philips’ LumiGuide "human...
A proposal to save vascular surgery
In response to recent articles in the lay press suggesting vascular surgeons were performing unnecessary procedures, Vascular Specialist medical editor, Malachi Sheahan, has asked...
Could metformin be first-ever medical treatment that is effective at managing...
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is...
‘There is no reliable way to measure carotid stenosis—methods have changed...
The recent move to expand Medicare coverage of carotid stenting formed the basis of a recent debate over the wisdom of the decision taken...
Changing course: The natural history of tibial claudication comes under scrutiny...
In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the...
Vascular Specialist–December 2023
In this issue:
Changing course: The natural history of tibial claudication comes under scrutiny as interventions for "relatively benign" disease trend upward
Our guest editorial...
Intravenous anesthesia delivery during varicose vein treatment proves safe and reduces...
A new intravenous anesthesia delivery technique used during endothermal ablation for varicose veins demonstrated comparatively low pain scores according to first-in-human (FIH) data recently...
TRANSCEND 36-month data “continue to demonstrate safe and effective performance” of...
Peter Schneider (University of California San Francisco, San Francisco, USA) recently presented 36-month data from Surmodics' TRANSCEND clinical trial at the VEITHsymposium 2023 (14–18...
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented...
Xeltis has announced "highly encouraging" 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical...
Randomized trial set to elucidate value of image fusion technology for...
An ongoing UK National Institute for Health and Care Research (NIHR)-funded randomized controlled trial seeks to illuminate the value of an image fusion guidance...
Two-year SWING data ‘continue to show promise’ for sirolimus DCB in...
Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been...
Specialty representation at all levels of a healthcare organization is ‘increasingly...
A 14-year effort to achieve departmental status for vascular surgery at a large healthcare system in Southern California resulted in significant gains for the...